156 related articles for article (PubMed ID: 29148245)
1. A brain-heart team approach to PFO.
Garratt KN; Horlick E; Kavinsky C; Rosenfield K
Catheter Cardiovasc Interv; 2017 Nov; 90(6):879-880. PubMed ID: 29148245
[No Abstract] [Full Text] [Related]
2. A Review of Transcatheter Closure of Patent Foramen Ovale.
Neill J; Lin CH
Methodist Debakey Cardiovasc J; 2017; 13(3):152-159. PubMed ID: 29744000
[TBL] [Abstract][Full Text] [Related]
3. SCAI expert consensus statement on operator and institutional requirements for PFO closure for secondary prevention of paradoxical embolic stroke: The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists.
Horlick E; Kavinsky CJ; Amin Z; Boudoulas KD; Carroll JD; Hijazi ZM; Leifer D; Lutsep HL; Rhodes JF; Tobis JM
Catheter Cardiovasc Interv; 2019 Apr; 93(5):859-874. PubMed ID: 30896894
[TBL] [Abstract][Full Text] [Related]
4. Double standards in the world of ASD and PFO management: closure for paradoxical embolism.
Carroll JD
Catheter Cardiovasc Interv; 2009 Dec; 74(7):1070-1. PubMed ID: 19950331
[No Abstract] [Full Text] [Related]
5. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
6. Transcatheter Patent Foramen Ovale Closure After Cryptogenic Stroke: An Updated Meta-Analysis of Randomized Trials.
Mojadidi MK; Elgendy AY; Elgendy IY; Mahmoud AN; Elbadawi A; Eshtehardi P; Patel NK; Wayangankar S; Tobis JM; Meier B
JACC Cardiovasc Interv; 2017 Nov; 10(21):2228-2230. PubMed ID: 29122137
[No Abstract] [Full Text] [Related]
7. Patent Foramen Ovale Closure for Stroke Prevention and Other Disorders.
Collado FMS; Poulin MF; Murphy JJ; Jneid H; Kavinsky CJ
J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29910192
[No Abstract] [Full Text] [Related]
8. Another addition to the tool box.
Tuzcu EM
Catheter Cardiovasc Interv; 2008 May; 71(6):829-30. PubMed ID: 18412080
[No Abstract] [Full Text] [Related]
9. Is the hole only a part of the whole?
Block PC
JACC Cardiovasc Interv; 2009 Jul; 2(7):663-4. PubMed ID: 19628190
[No Abstract] [Full Text] [Related]
10. New aspects of paradoxical embolism.
Lehmeyer S; Lindhoff-Last E
Vasa; 2011 Jan; 40(1):31-40. PubMed ID: 21283971
[TBL] [Abstract][Full Text] [Related]
11. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.
Luermans JG; Post MC; Schräder R; Sluysmans T; Vydt T; Vermeersch P; Chessa M; Onorato E; Goy JJ; Budts WI
Catheter Cardiovasc Interv; 2008 May; 71(6):822-8. PubMed ID: 18324695
[TBL] [Abstract][Full Text] [Related]
12. The paradox of paradoxical embolism and recurrent stroke.
Abou-Chebl A
JACC Cardiovasc Interv; 2014 Aug; 7(8):921-2. PubMed ID: 25147038
[No Abstract] [Full Text] [Related]
13. Propensity Score-Based Analysis of Percutaneous Closure Versus Medical Therapy in Patients With Cryptogenic Stroke and Patent Foramen Ovale: The IPSYS Registry (Italian Project on Stroke in Young Adults).
Pezzini A; Grassi M; Lodigiani C; Patella R; Gandolfo C; Zini A; DeLodovici ML; Paciaroni M; Del Sette M; Toriello A; Musolino R; Calabrò RS; Bovi P; Adami A; Silvestrelli G; Sessa M; Cavallini A; Marcheselli S; Marco Bonifati D; Checcarelli N; Tancredi L; Chiti A; Del Zotto E; Tomelleri G; Spalloni A; Giorli E; Costa P; Giacalone G; Ferrazzi P; Poli L; Morotti A; Piras V; Rasura M; Simone AM; Gamba M; Cerrato P; Zedde ML; Micieli G; Melis M; Massucco D; Guido D; De Giuli V; Bonaiti S; D'Amore C; La Starza S; Iacoviello L; Padovani A;
Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582111
[TBL] [Abstract][Full Text] [Related]
14. Recurrent events following patent foramen ovale closure in patients above 55 years of age with presumed paradoxical embolism.
Spies C; Khandelwal A; Timmemanns I; Kavinsky CJ; Schräder R; Hijazi ZM
Catheter Cardiovasc Interv; 2008 Dec; 72(7):966-70. PubMed ID: 18942060
[TBL] [Abstract][Full Text] [Related]
15. Patent foramen ovale and cryptogenic stroke.
Nakanishi K; Yoshiyama M; Homma S
Trends Cardiovasc Med; 2017 Nov; 27(8):575-581. PubMed ID: 28709812
[TBL] [Abstract][Full Text] [Related]
16. Implantation of a Occlutech Figulla PFO occluder in a patient with patent foramen ovale and history of embolic stroke.
Krecki R; Peruga JZ; Plewka M; Krzemińska-Pakuła M; Kasprzak JD
Cardiol J; 2008; 15(4):380-2. PubMed ID: 18698549
[TBL] [Abstract][Full Text] [Related]
17. Paradoxical embolism through the patent foramen ovale--the elderly is where the money is.
Meier B
Catheter Cardiovasc Interv; 2008 Dec; 72(7):971-2. PubMed ID: 19021283
[No Abstract] [Full Text] [Related]
18. Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience.
Taggart NW; Reeder GS; Lennon RJ; Slusser JP; Freund MA; Cabalka AK; Cetta F; Hagler DJ
Catheter Cardiovasc Interv; 2017 Jan; 89(1):124-133. PubMed ID: 27027873
[TBL] [Abstract][Full Text] [Related]
19. Echocardiographic features of PFOs and paradoxical embolism: a complicated puzzle.
Aggeli C; Verveniotis A; Andrikopoulou E; Vavuranakis E; Toutouzas K; Tousoulis D
Int J Cardiovasc Imaging; 2018 Dec; 34(12):1849-1861. PubMed ID: 29956022
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous closure of patent foramen ovale: a near-perfect treatment ruined by careful study?
Kent DM; Kitsios GD
Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):414-5. PubMed ID: 22592756
[No Abstract] [Full Text] [Related]
[Next] [New Search]
